Curaleaf Holdings (CURLF) Notes Payables (2021 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Notes Payables of $35.7 million for Q4 2025, down 64.88% year-on-year from $101.7 million in Q4 2024, and down 64.88% on a QoQ basis from $101.7 million in Q4 2024.

Curaleaf Holdings (CURLF) Notes Payables (2021 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Notes Payables for 5 consecutive years, with $35.7 million the latest figure, recorded in Q4 2025.

  • Quarterly Notes Payables fell 64.88% year-over-year to $35.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $35.7 million (down 64.88% YoY) and the FY2025 annual result came in at $35.7 million, down 64.88% from the prior year.
  • Notes Payables retreated to $35.7 million in Q4 2025 per CURLF's latest filing, from $101.7 million in the prior quarter.
  • Over the last five years, Notes Payables for CURLF reached as high as $102.9 million in Q2 2024 and fell as low as $2.0 million in Q4 2021.
  • A 5-year average of $61.4 million and a median of $51.9 million in 2022 frame the typical range for Notes Payables.
  • Annual changes were most pronounced in 2022 — Notes Payables surged 2538.96% — and 2025, when it plunged 64.88%.
  • Year by year, Notes Payables stood at $2.0 million in 2021, then jumped by 2538.96% to $51.9 million in 2022, then declined by 23.91% to $39.5 million in 2023, then jumped by 157.67% to $101.7 million in 2024, then tumbled by 64.88% to $35.7 million in 2025.
  • According to Business Quant data, Notes Payables over the past three periods registered $35.7 million, $101.7 million, and $95.9 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 35.73 Mn
Dec 31, 2024 101.72 Mn
Sep 30, 2024 95.95 Mn
Jun 30, 2024 102.95 Mn
Dec 31, 2023 39.48 Mn
Dec 31, 2022 51.88 Mn
Dec 31, 2021 1.97 Mn